SAGE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.69 USD | +0.81% |
|
+2.70% | -36.83% |
| Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
| Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 16.42 | 19.04 | 26.55 |
| Spread/Res. | -16.63% | -28.10% | -48.44% |
| Spread/Supp. | +8.91% | +8.91% | +2.70% |
| Support | 12.57 | 12.57 | 13.33 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SAGE Stock
- Charts Sage Therapeutics, Inc.
